0001209191-22-047428.txt : 20220824
0001209191-22-047428.hdr.sgml : 20220824
20220824210055
ACCESSION NUMBER: 0001209191-22-047428
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220228
FILED AS OF DATE: 20220824
DATE AS OF CHANGE: 20220824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galindo Alejandro
CENTRAL INDEX KEY: 0001821447
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50865
FILM NUMBER: 221192768
MAIL ADDRESS:
STREET 1: 30930 RUSSELL RANCH RD
STREET 2: STE 300
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MANNKIND CORP
CENTRAL INDEX KEY: 0000899460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133607736
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CASPER STREET
CITY: DANBURY
STATE: CT
ZIP: 06810
BUSINESS PHONE: 818-661-5000
MAIL ADDRESS:
STREET 1: 1 CASPER STREET
CITY: DANBURY
STATE: CT
ZIP: 06810
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-02-28
2022-02-28
0
0000899460
MANNKIND CORP
MNKD
0001821447
Galindo Alejandro
1 CASPER STREET
DANBURY
CT
06810
0
1
0
0
EVP Endocrine Business Unit
Common Stock,$.01 par value
2022-02-28
4
A
0
36900
2.71
A
576690
D
This Form 4 is being amended to correct the transaction code. The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective February 28, 2022. The purchase was approved by the Company's Board of Directors.
/s/ Alejandro Galindo
2022-08-24